Entrada Therapeutics, Inc. - Common Stock — 四半期財務統計 (NASDAQ:TRDA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -31.61 M-38.51 M-29.49 M-28.31 M-32.2 M-41.7 M -131.7 M 投資活動によるキャッシュフロー 53.37 M4.78 M33.8 M49.11 M29.12 M26.99 M 139.01 M 財務活動によるキャッシュフロー 1.4 M350 K337 K8 000192 K100 K 637 K フリーキャッシュフロー -31.61 M-38.51 M-29.76 M-28.14 M-32 M-41.74 M -131.64 M

ニュース

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

ダウが350ポイント下落、USフーズが悲観的な決算を発表

Sarepta Dives; Can 2026 Be The Reset Year For Its Controversial Gene Therapy?

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Misses Revenue Estimates

Entrada Therapeutics (TRDA) Surges 8.9%: Is This an Indication of Further Gains?

Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates

【決算速報】Entrada Therapeutics、売上高は予想を下回り、利益は予想を上回る結果に

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?